Genetic variation in six SNPs in PPARD inpatients with impaired glucose tolerance and association with the conversion totype 2 DM in response to acarbose was investigated in the STOP-NIDDM trial [72, 73]. The gene discussed is PPARD; the disease is type 2 diabetes mellitus.